• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtech trends: The most talked about device makers in March 2014

Medtech trends: The most talked about device makers in March 2014

April 2, 2014 By Arezu Sarvestani

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

There were some major upsets in the trends hierarchy in March, but not at the top where Medtronic (NYSE:MDT) continues to reign as the most talked-about and searched-for medtech company around. The titan was the subject of a slew of headlines, including rumors of the company’s involvement with an orgasm stimulation implant and the highly anticipated outcome of the company’s renal denervation trial.

Covidien (NYSE:COV) jumped to the 2nd-place spot, prompted in part by news that company president & CEO Jose Almeida was tapped as the new chairman of the board for medtech lobbying group AdvaMed. St. Jude Medical (NYSE:STJ) moved up as well, taking 3rd place with news of its ongoing legal war with Volcano (NSDQ:VOLC) and updates on its Nanostim pacemaker.

Boston Scientific (NYSE:BSX) remained in 4th place, releasing updates on its legal activities, tussling with Medtronic and landing regulatory wins in the European Union. GE Healthcare (NYSE:GE) rejoined the top 5, although the company was hit with bad news of a high-risk recall and being named one of the worst-performing medtech makers of the year.

Medtronic log

Medtronic

  • Medtronic vet takes over marketing at Vexim
  • Diabetes: Medtronic teams up with Aetna to tackle Type II diabetes
  • Europe spikes Edwards Lifesciences’ TAVI patent in war with Medtronic
  • Report: Medtronic signs on to test on-demand orgasm device
  • UPDATED: Medtronic denies involvement with on-demand orgasm implant
  • Chinese study compares Medtronic spine implants
  • Appeals court applies Supreme Court ruling to Medtronic lawsuit against Boston Scientific
  • Itamar Medical inks distribution deals with Medtronic, Philips
  • AIM: Medtronic, St. Jude recalls illustrate why PMA modifications don’t work
  • Medtronic details humanitarian sales to Syria, Cuba, Sudan
  • Medtech gears up for Medtronic’s RDN trial results
  • Urologix still owes Medtronic $650k
  • Medtronic launches cardiac arrest trial for developing nations
  • Medtronic can skip FDA panel on positive high-risk CoreValve data
  • Medtronic details Symplicity renal denervation data
  • Sapien XT bests CoreValve in small head-to-head study
  • UPDATE: Reaction to Medtronic’s Symplicity renal denervation data
Covidien logo

Covidien

  • Covidien touts U.S, European wins for new ventilator
  • Covidien’s ev3 seeks new trial in $175M loss to Appriva
  • Covidien’s Barrx ablation system stems progression of esophagus disease, study says
  • Covidien chief Almeida to chair AdvaMed’s board
St. Jude Medical logo

St. Jude Medical

  • Volcano loses round in FFR war with St. Jude Medical
  • St. Jude Medical launches post-approval Nanostim trial in Europe
  • Volcano appeals loss to St. Jude Medical in FFR war
  • St. Jude’s Prodigy chronic pain Nuristan device lands CE Mark
  • St. Jude Medical’s Allure Quadra pacemaker wins FDA OK
  • AIM: Medtronic, St. Jude recalls illustrate why PMA modifications don’t work
  • St. Jude’s Nanostim pacemaker looks good at 3 months in feasibility study
Boston Scientific logo

Boston Scientific

  • Boston Scientific legal update: Pelvic mesh looms, Guidant makes progress
  • Appeals court applies Supreme Court ruling to Medtronic lawsuit against Boston Scientific
  • Boston Scientific lands E.U. approval for Rebel bare-metal stent
  • Boston Scientific’s Ingevity MRI-safe cardiac pacing leads win EU nod
  • Study shows long-term benefits for some CRT-D patients
GE Healthcare logo

GE Healthcare

  • Another Class I recall for GE Healthcare
  • Siemens, GE named among worst-performing device makers of the year
  • Pentagon exercises $150M contract options with Philips, GE Healthcare

Filed Under: News Well Tagged With: Boston Scientific, Covidien, GE Healthcare, stjudemedical, Trends

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy